MedTrace Logo

China PEACE-Prospective PCI Study

NCT01624922 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5185

Last updated 2015-08-31

No results posted yet for this study

Summary

Coronary heart disease (CHD) pose a serious health threaten to population. PCI, as a well-proved and booming measure in CHD management, is invasive and of high cost, however the knowledge about the real-life PCI use in China is limited. By consecutively recruiting PCI patients in 30 geographically representative highest-rank hospitals, this study will examine various real-life factors, that may affect patients recovery after the procedure. Practical guidelines, appropriateness criteria and quality evaluative system for PCI will be established based on the findings, to improve patients outcomes in future finally.

Conditions

Sponsors & Collaborators

  • Ministry of Health, China

    collaborator OTHER_GOV

  • China National Center for Cardiovascular Diseases

    lead OTHER_GOV

Principal Investigators

  • Lixin Jiang, M.D., Ph.D. · China National Center for Cardiovascular Diseases

  • Harlan M Krumholz, M.D., S.M. · Yale University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2013-08-31
Completion
2015-07-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01624922 on ClinicalTrials.gov